Detection of Alzheimer Neuropathology in Alzheimer and Non-Alzheimer Clinical Syndromes With Blood-Based Biomarkers

额颞叶变性 神经病理学 阿尔茨海默病 生物标志物 医学 尸检 病理 痴呆 神经纤维缠结 病态的 疾病 失智症 内科学 肿瘤科 心理学 老年斑 生物 生物化学
作者
Lawren A. VandeVrede,Hanna Cho,Mark E. Sanderson‐Cimino,Fattin Wekselman,Yann Cobigo,Maria Luisa Gorno‐Tempini,Hilary W. Heuer,Joel H. Kramer,Argentina Lario Lago,Dana Leichter,Peter Alexander Ljubenkov,Bruce L. Miller,David C. Perry,Gil Dan Rabinovici,Julio C. Rojas,Howard J. Rosen,Rowan Saloner,Adam M. Staffaroni,Gallen Triana‐Baltzer,Salvatore Spina
出处
期刊:JAMA Neurology [American Medical Association]
卷期号:82 (4): 344-344 被引量:69
标识
DOI:10.1001/jamaneurol.2024.5017
摘要

Importance: Blood-based biomarkers for Alzheimer disease (AD) are clinically available, but their value is not well understood in syndromes typically associated with frontotemporal lobar degeneration syndromes (FTLD). Objective: To investigate the clinical importance and detectability of AD in FTLD-related neurodegenerative syndromes using 3 plasma biomarkers, phosphorylated tau 217 (p-tau217), neurofilament light chain (NfL), and glial fibrillary acidic protein (GFAP). Design, Setting, and Participants: This clinicopathological study took place at the University of California San Francisco Alzheimer Disease Research Center from August 2008 to July 2022. Autopsied individuals with clinical evaluation and neuropathological examination, diagnosed with clinical syndromes related to AD (n = 125), frontotemporal lobar degeneration (FTLD; n = 198), or cognitively unimpaired (CU) at the time of evaluation (n = 16) were included. Exposures: AD-related or FTLD-related clinical syndromes or CU. Main Outcomes and Measures: P-tau217, NfL, and GFAP were measured with single-molecule array (SIMOA). AD was defined as intermediate or high AD neuropathological change (ADNC) at autopsy. Clinical biomarker associations were evaluated using linear regressions. Imaging analyses used bayesian linear mixed-effects modeling. Results: A total of 349 individuals (191 [55%] male; mean [SD] age at death, 72 [11] years) were included. AD was common in both AD-related syndromes (110/125 [88%]) and FTLD-related syndromes (45/198 [23%]). Neuropathological stage at autopsy was higher in AD-related syndromes (high ADNC: 82/88 [93%] AD vs 13/23 [56%] FTLD), and AD was frequently considered a copathology in FTLD-related syndromes (30/198 [15%]). Plasma p-tau217 concentrations were higher in AD-related syndromes (mean [SD], 0.28 [0.16] pg/mL) than FTLD-related syndromes (mean [SD], 0.10 [0.09] pg/mL) (P < .05). Plasma p-tau217 concentrations were highest in atypical AD-related syndromes (mean [SD], 0.33 [0.02] pg/mL), followed by typical late-onset amnestic syndromes (mean [SD], 0.27 [0.03] pg/mL). FTLD-related syndromes with AD (mean [SD], 0.19 [0.02] pg/mL) were higher compared to without (mean [SD], 0.07 [0.00] pg/mL). Plasma p-tau217 detected AD neuropathology across syndromes (area under the receiver operating characteristic curve [AUC], 0.95; 95% CI, 0.93-0.97), with slightly better performance in AD-related syndromes (AUC, 0.98; 95% CI, 0.95-1.00) compared to FTLD-related syndromes (AUC, 0.89; 95% CI, 0.83-0.94). NfL and GFAP had lower performance for detecting AD (AUC, 0.73; 95% CI, 0.68-0.78 and AUC, 0.75; 95% CI, 0.67-0.80, respectively) and added little to no diagnostic value either alone or in combinations with p-tau217. The presence of AD in FTLD-related syndromes was associated with lower Mini-Mental State Examination score (mean [SD], -2.90 [1.09]; P < .05), worse performance on memory (mean [SD] z score, -0.64 [0.32]), executive (mean [SD] z score, -0.74 [0.19]), and visuospatial composites (mean [SD] z score, -0.88 [0.37]) as well as increased rates of posterior cortical atrophy. Conclusion: Clinically relevant AD was prevalent across neurodegenerative syndromes and detectable with plasma p-tau217. Plasma p-tau217 may be a useful tool to investigate the clinical impact of AD copathology in non-AD neurodegenerative syndromes, including the effect of disease-modifying therapies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
去码头吃薯条完成签到 ,获得积分10
刚刚
清辉影发布了新的文献求助10
1秒前
1秒前
万能图书馆的应助被小小采纳,获得10
1秒前
香蕉觅云的应助被zhao采纳,获得10
1秒前
无花果的应助被Sky采纳,获得10
1秒前
zqxu发布了新的文献求助10
2秒前
2秒前
今后的应助被qin202569采纳,获得10
2秒前
2秒前
xiangshu完成签到,获得积分10
2秒前
2秒前
Chenszy完成签到,获得积分10
2秒前
3秒前
清辉影发布了新的文献求助80
3秒前
AAANICK完成签到,获得积分10
3秒前
3秒前
4秒前
4秒前
4秒前
123发布了新的文献求助10
5秒前
5秒前
研友_VZG7GZ的应助被corleeang采纳,获得10
5秒前
n11发布了新的文献求助10
5秒前
李李完成签到,获得积分10
5秒前
5秒前
yolo完成签到 ,获得积分10
5秒前
6秒前
所所的应助被songsheng采纳,获得10
6秒前
zzhou完成签到,获得积分10
6秒前
Yy发布了新的文献求助10
6秒前
情怀的应助被核桃采纳,获得10
6秒前
晴天发布了新的文献求助10
7秒前
顾矜的应助被核桃采纳,获得10
7秒前
清辉影发布了新的文献求助10
7秒前
清辉影发布了新的文献求助10
7秒前
田様的应助被核桃采纳,获得10
7秒前
清辉影发布了新的文献求助30
7秒前
共享精神的应助被核桃采纳,获得10
7秒前
清辉影发布了新的文献求助10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183142
求助须知:如何正确求助?哪些是违规求助? 9572420
关于积分的说明 21825253
捐赠科研通 7779922
什么是DOI,文献DOI怎么找? 3433850
关于科研通互助平台的介绍 2558060
邀请新用户注册赠送积分活动 2480124